Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 599, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.ijpharm.2021.120438
Keywords
Cancer; Nanomedicine; Chemotherapy; Drug delivery; Nanodrugs
Categories
Funding
- CIBER-BBN [DTS19/00162, PID2019-106386RB-I00]
Ask authors/readers for more resources
Nanomedicine offers a promising approach towards personalized medicine for cancer patients, with novel tools being developed for treatment, imaging, and theranostic purposes. Despite successful preclinical studies, promising nanosystems face obstacles before being adopted as safe options for cancer patients in clinical practice.
Cancer has reached pandemic dimensions in the whole world. Although current medicine offers multiple treatment options against cancer, novel therapeutic strategies are needed due to the low specificity of chemotherapeutic drugs, undesired side effects and the presence of different incurable types of cancer. Among these new strategies, nanomedicine arises as an encouraging approach towards personalized medicine with high potential for present and future cancer patients. Therefore, nanomedicine aims to develop novel tools with wide potential in cancer treatment, imaging or even theranostic purposes. Even though numerous preclinical studies have been published with successful preliminary results, promising nanosystems have to face multiple obstacles before adoption in clinical practice as safe options for patients with cancer. In this MiniReview, we provide a short overview on the latest advances in current nanomedicine approaches, challenges and promising strategies towards more accurate cancer treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available